GC
AMGN icon

Grimes & Company’s Amgen AMGN Stock Holding History

Grimes & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2M Sell
80,582
-6
-0% -$2.05K 0.63% 35
2026
Q1 		$28.4M Sell
80,588
-1,541
-2% -$549K 0.78% 21
2025
Q4 		$26.9M Sell
82,129
-4,111
-5% -$1.3M 0.64% 32
2025
Q3 		$24.3M Sell
86,240
-5,439
-6% -$1.58M 0.6% 32
2025
Q2 		$25.6M Buy
91,679
+145
+0.2% +$41.1K 0.7% 27
2025
Q1 		$28.5M Sell
91,534
-730
-0.8% -$216K 0.88% 20
2024
Q4 		$24M Buy
92,264
+760
+0.8% +$225K 0.69% 31
2024
Q3 		$29.5M Sell
91,504
-2,217
-2% -$725K 0.8% 24
2024
Q2 		$29.3M Buy
93,721
+575
+0.6% +$169K 0.88% 25
2024
Q1 		$26.5M Buy
93,146
+1,715
+2% +$502K 0.81% 26
2023
Q4 		$26.3M Buy
91,431
+647
+0.7% +$176K 0.87% 23
2023
Q3 		$24.4M Sell
90,784
-3,900
-4% -$973K 0.94% 21
2023
Q2 		$21M Buy
94,684
+257
+0.3% +$59.6K 0.75% 22
2023
Q1 		$22.8M Buy
94,427
+2,961
+3% +$727K 0.94% 18
2022
Q4 		$24M Buy
91,466
+1,414
+2% +$379K 1.01% 14
2022
Q3 		$20.3M Buy
90,052
+587
+0.7% +$142K 1.06% 13
2022
Q2 		$21.8M Sell
89,465
-8,579
-9% -$2.1M 1.1% 12
2022
Q1 		$23.7M Buy
98,044
+6,463
+7% +$1.48M 1.24% 16
2021
Q4 		$20.6M Buy
91,581
+1,848
+2% +$390K 0.94% 25
2021
Q3 		$19.1M Buy
89,733
+4,869
+6% +$1.12M 0.83% 26
2021
Q2 		$20.7M Buy
84,864
+3,362
+4% +$827K 0.9% 23
2021
Q1 		$20.3M Buy
81,502
+15,849
+24% +$3.78M 0.98% 23
2020
Q4 		$15.1M Buy
65,653
+10,398
+19% +$2.4M 0.78% 29
2020
Q3 		$14M Sell
55,255
-2,095
-4% -$519K 0.9% 26
2020
Q2 		$13.5M Sell
57,350
-536
-0.9% -$122K 0.94% 27
2020
Q1 		$11.7M Sell
57,886
-4,216
-7% -$921K 1.07% 18
2019
Q4 		$15M Sell
62,102
-2,022
-3% -$446K 0.98% 24
2019
Q3 		$12.4M Buy
64,124
+752
+1% +$144K 0.88% 22
2019
Q2 		$11.7M Buy
63,372
+889
+1% +$159K 0.89% 23
2019
Q1 		$11.9M Buy
62,483
+1,558
+3% +$298K 0.93% 25
2018
Q4 		$11.9M Buy
60,925
+340
+0.6% +$66.3K 1.16% 15
2018
Q3 		$12.6M Buy
60,585
+882
+1% +$174K 1.01% 24
2018
Q2 		$11M Sell
59,703
-1,203
-2% -$213K 0.97% 26
2018
Q1 		$10.4M Buy
60,906
+6,483
+12% +$1.19M 1.01% 24
2017
Q4 		$9.46M Buy
54,423
+633
+1% +$112K 0.91% 29
2017
Q3 		$10M Sell
53,790
-51
-0.1% -$9.04K 1.07% 22
2017
Q2 		$9.27M Buy
53,841
+52,599
+4,235% +$8.56M 1.03% 24
2017
Q1 		$204K Buy
+1,242
New +$206K 0.02% 190
2016
Q4 		– Sell
-1,242
Closed -$207K – 200
2016
Q3 		$207K Buy
+1,242
New +$210K 0.03% 183

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Grimes & Company's AMGN Position: Q2 2026 in Review

Grimes & Company reduced its Amgen (AMGN) stake by 0.01% in Q2 2026, selling an estimated $2.05K and leaving 80,582 shares worth $29.2M. The position accounts for 0.63% of the portfolio, ranked #35.

Grimes & Company first reported a position in AMGN in Q3 2016 and has held it in 39 quarters since. The position peaked at $29.5M in Q3 2024. 1,245 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Grimes & Company held 80,582 shares of Amgen worth $29.2M as of Q2 2026.
  • Grimes & Company sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.63% of Grimes & Company's portfolio in Q2 2026, its #35 holding.
  • Grimes & Company first reported a position in Amgen in Q3 2016 and has held it in 39 quarters since.
  • Grimes & Company's Amgen position peaked at $29.5M in Q3 2024.
  • 1,245 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.